Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 Jul 2021
Historique:
received: 18 06 2021
accepted: 07 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 20 8 2021
Statut: epublish

Résumé

A heterogeneous genetic subtype of B-cell precursor acute lymphoblastic leukemia is driven by constitutive kinase-activation, including patients with JAK2 fusions. In our study, we model the impact of a novel JAK2 fusion protein on hematopoietic development in human induced pluripotent stem cells (hiPSCs). We insert the

Identifiants

pubmed: 34299194
pii: ijms22147576
doi: 10.3390/ijms22147576
pmc: PMC8304339
pii:
doi:

Substances chimiques

Core Binding Factor Alpha 2 Subunit 0
MYC protein, human 0
Oncogene Proteins, Fusion 0
Proto-Oncogene Proteins c-myc 0
RUNX1 protein, human 0
STAT Transcription Factors 0
JAK2 protein, human EC 2.7.10.2
Janus Kinase 2 EC 2.7.10.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Österreichische Forschungsförderungsgesellschaft
ID : 843456
Organisme : Austrian Society for Pediatrics and Adolescent Medicine
ID : ÖGKJ scientific prize 2016

Références

Cell Stem Cell. 2017 Mar 2;20(3):315-328.e7
pubmed: 28215825
Leukemia. 2010 Aug;24(8):1516-9
pubmed: 20520637
Methods Mol Biol. 2019;1953:105-119
pubmed: 30912018
Oncogene. 2013 May 23;32(21):2601-13
pubmed: 22869151
Stem Cell Res. 2019 Dec;41:101600
pubmed: 31710911
Nature. 2017 May 11;545(7653):229-233
pubmed: 28445466
Stem Cell Reports. 2016 Oct 11;7(4):602-618
pubmed: 27666791
Blood. 2013 Dec 12;122(25):4035-46
pubmed: 24124087
Stem Cell Reports. 2020 Jan 14;14(1):122-137
pubmed: 31839543
Leukemia. 2007 Aug;21(8):1843-5
pubmed: 17443220
Best Pract Res Clin Haematol. 2017 Sep;30(3):212-221
pubmed: 29050694
Stem Cells. 2004;22(7):1191-204
pubmed: 15579639
Int J Cancer. 2017 Mar 1;140(5):1000-1008
pubmed: 27778348
Blood. 1998 Jun 1;91(11):4028-37
pubmed: 9596646
Cell Stem Cell. 2017 Mar 2;20(3):329-344.e7
pubmed: 28089908
Nat Biotechnol. 2016 Feb;34(2):184-191
pubmed: 26780180
Hemasphere. 2019 Dec 16;4(1):e312
pubmed: 32072137
Blood. 2015 Feb 19;125(8):1282-91
pubmed: 25515960
Genes Dev. 2018 Jun 1;32(11-12):849-864
pubmed: 29907650
Blood. 2006 Sep 15;108(6):2095-105
pubmed: 16757688
Nature. 2009 Oct 8;461(7265):819-22
pubmed: 19783980
Genes (Basel). 2017 May 13;8(5):
pubmed: 28505071
Acta Haematol. 2019;142(2):105-112
pubmed: 31063994
Genome Biol. 2014;15(12):550
pubmed: 25516281
Stem Cells. 2017 Sep;35(9):2095-2102
pubmed: 28758276
Nat Rev Cancer. 2008 Jan;8(1):51-6
pubmed: 18046334
Cancer Genet Cytogenet. 2002 Jun;135(2):110-9
pubmed: 12127395
Nucleic Acids Res. 2013 May 1;41(10):e108
pubmed: 23558742
Blood. 2017 Apr 13;129(15):2070-2082
pubmed: 28179279
Nature. 2009 Feb 12;457(7231):887-91
pubmed: 19129762
Curr Opin Oncol. 2007 Jan;19(1):55-60
pubmed: 17133113
Blood. 2013 Apr 11;121(15):2882-90
pubmed: 23372166
J Exp Med. 2011 Jun 6;208(6):1135-49
pubmed: 21606506
Science. 1997 Nov 14;278(5341):1309-12
pubmed: 9360930
J Exp Med. 2004 Sep 6;200(5):623-35
pubmed: 15353555
Development. 2018 Mar 12;145(5):
pubmed: 29530939
Hemasphere. 2018 Jun 20;2(4):e53
pubmed: 31723781
Hepatology. 2010 Nov;52(5):1808-18
pubmed: 21038417
Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10431-4
pubmed: 1720541
Front Cell Dev Biol. 2017 Dec 20;5:111
pubmed: 29326930
Nat Methods. 2015 Sep;12(9):823-6
pubmed: 26167643
Blood. 2007 Oct 15;110(8):2880-8
pubmed: 17630355
Leukemia. 2018 Aug;32(8):1713-1726
pubmed: 29728695
Cell. 2012 Sep 28;151(1):56-67
pubmed: 23021215
Biostatistics. 2017 Apr 1;18(2):275-294
pubmed: 27756721
Exp Hematol. 2007 Nov;35(11):1668-76
pubmed: 17976519
Stem Cells Dev. 2018 Oct 1;27(19):1376-1384
pubmed: 30009677
J Cell Sci. 2004 Mar 15;117(Pt 8):1281-3
pubmed: 15020666
Br J Haematol. 2017 Mar;176(6):867-882
pubmed: 27984637
Nat Chem Biol. 2018 May;14(5):431-441
pubmed: 29581585
Haematologica. 2016 Apr;101(4):407-16
pubmed: 27033238
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Front Oncol. 2018 Jul 31;8:287
pubmed: 30109213
Eur J Hum Genet. 2017 Aug;25(8):1020-1024
pubmed: 28513614
J Biochem. 1997 Nov;122(5):977-82
pubmed: 9443813
Dev Cell. 2018 Feb 5;44(3):362-377.e7
pubmed: 29290585
Methods Mol Biol. 2004;263:67-94
pubmed: 14976361
Cell Res. 2018 Feb;28(2):172-186
pubmed: 29148541
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cancer Lett. 2013 May 10;332(1):30-4
pubmed: 23340173
Mol Cell Biol. 2008 Nov;28(21):6668-80
pubmed: 18779318
Curr Opin Immunol. 2010 Apr;22(2):168-76
pubmed: 20227268
Leukemia. 2018 Jan;32(1):38-48
pubmed: 28555080
Nat Genet. 2020 Jul;52(7):662-668
pubmed: 32424350
Cytokine. 2019 Jun;118:48-63
pubmed: 29685781
Cold Spring Harb Perspect Med. 2020 Jul 1;10(7):
pubmed: 31653664
Blood. 2015 Jun 4;125(23):3570-9
pubmed: 25911237
Haematologica. 2015 Oct;100(10):1240-53
pubmed: 26432382
Growth Factors. 2011 Dec;29(6):245-52
pubmed: 21892841
Semin Cancer Biol. 2006 Aug;16(4):288-302
pubmed: 16938463
Nat Methods. 2015 Feb;12(2):115-21
pubmed: 25633503
Haematologica. 2014 Apr;99(4):e52-4
pubmed: 24510341
Adv Exp Med Biol. 2017;962:47-64
pubmed: 28299650
Nature. 2017 May 25;545(7655):432-438
pubmed: 28514439
Nature. 2020 Jul;583(7818):845-851
pubmed: 32699415
Nucleic Acids Res. 2020 Jan 24;48(2):974-995
pubmed: 31799604
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3444-9
pubmed: 8622955
Nat Commun. 2017 Sep 22;8(1):657
pubmed: 28939824
Bioinformatics. 2015 Sep 15;31(18):3078-80
pubmed: 25979474
N Engl J Med. 2014 Sep 11;371(11):1005-15
pubmed: 25207766

Auteurs

Klaus Fortschegger (K)

St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.

Anna-Maria Husa (AM)

St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.

Dagmar Schinnerl (D)

St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.

Karin Nebral (K)

St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.

Sabine Strehl (S)

St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH